AAIS
AZN icon

ABN AMRO Investment Solutions’s AstraZeneca AZN Stock Holding History

ABN AMRO Investment Solutions’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-6,941
Closed -$1.08M – 447
2024
Q3 		$1.08M Buy
+6,941
New +$1.12M 0.02% 303
2023
Q3 		– Sell
-3,109
Closed -$445K – 410
2023
Q2 		$445K Buy
3,109
+167
+6% +$24.6K 0.01% 348
2023
Q1 		$408K Buy
+2,942
New +$396K 0.01% 362

Other funds holding AZN

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return

ABN AMRO Investment Solutions's AZN Position: Q4 2024 in Review

ABN AMRO Investment Solutions sold out of AstraZeneca (AZN) in Q4 2024, closing a stake of 6,941 shares — an estimated $1.08M sold.

ABN AMRO Investment Solutions first reported a position in AZN in Q1 2023 and held it in 3 quarters. The position peaked at $1.08M in Q3 2024. 1,220 funds tracked by Wall St. Rank hold AZN as of Q4 2024.

  • ABN AMRO Investment Solutions reported no remaining AstraZeneca position as of Q4 2024 after selling out during the quarter.
  • ABN AMRO Investment Solutions sold 6,941 AstraZeneca shares in Q4 2024, an estimated $1.08M.
  • ABN AMRO Investment Solutions first reported a position in AstraZeneca in Q1 2023 and held it in 3 quarters.
  • ABN AMRO Investment Solutions's AstraZeneca position peaked at $1.08M in Q3 2024.
  • 1,220 funds tracked by Wall St. Rank held AstraZeneca as of Q4 2024.

Based on ABN AMRO Investment Solutions's 13F filing for Q4 2024, filed 4 Sep 2025.